MedPlus Health Services Limited has intimated the stock exchanges about an upcoming Board of Directors meeting scheduled for Friday, November 06, 2026. The primary agenda of this meeting is to consider a proposal for the buyback of the company's fully paid-up equity shares.
The buyback proposal will be evaluated in accordance with Sections 68, 69, and 70 of the Companies Act, 2013, along with the relevant rules, and the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, as amended.
Concurrently, the company has implemented a trading window closure for designated persons and their immediate relatives, effective from Friday, October 30, 2026. This closure will remain in effect until 48 hours after the outcome of the board meeting regarding the buyback proposal is made public.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR) and includes trading window closure requirements under SEBI (Prohibition of Insider Trading) Regulations, 2015.
The final outcome of the board meeting decision will be made available on the company's website (www.medplusindia.com) as well as on the websites of BSE Limited (www.bseindia.com) and National Stock Exchange of India Ltd. (www.nseindia.com).